Pharmaceuticals 2010, 3(6), 1873-1886; doi:10.3390/ph3061873

Cannabinoids and Viral Infections

Received: 21 May 2010; in revised form: 28 May 2010 / Accepted: 9 June 2010 / Published: 9 June 2010
(This article belongs to the Special Issue Cannabinoids)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: Exogenous cannabinoids or receptor antagonists may influence many cellular and systemic host responses. The anti-inflammatory activity of cannabinoids may compromise host inflammatory responses to acute viral infections, but may be beneficial in persistent infections. In neurons, where innate antiviral/pro-resolution responses include the activation of NOS-1, inhibition of Ca2+ activity by cannabinoids, increased viral replication and disease. This review examines the effect(s) of cannabinoids and their antagonists in viral infections.
Keywords: pathogens; virus infection; immunomodulation; inflammation
PDF Full-text Download PDF Full-Text [127 KB, uploaded 9 June 2010 16:38 CEST]

Export to BibTeX |

MDPI and ACS Style

Reiss, C.S. Cannabinoids and Viral Infections. Pharmaceuticals 2010, 3, 1873-1886.

AMA Style

Reiss CS. Cannabinoids and Viral Infections. Pharmaceuticals. 2010; 3(6):1873-1886.

Chicago/Turabian Style

Reiss, Carol Shoshkes. 2010. "Cannabinoids and Viral Infections." Pharmaceuticals 3, no. 6: 1873-1886.

Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert